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A previously healthy 26-year-old woman developed hemorrhagic alveolitis and adult
respiratory distress syndrome (ARDS) following use of a hydrofluoric acid-containing
household cleaning agent. Exposure was inhalational in nature. The circumstances and
possible mechanism of chemical pneumonitis from low-dose inhalational exposure to
hydrofluoric acid are discussed.Am. J. Ind. Med. 31:474–478, 1997.r 1997 Wiley-Liss, Inc.
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INTRODUCTION
Hydrogen fluoride (HF) is a weak acid existing as an
associated molecule up to H6F6 at 1 atm with temperatures of
,100°C; under these conditions, the average molecular
weight of the molecules is 50–55 Daltons [Stokinger, 1981].
It is infinitely soluble in cold water [Handbook of Physics
and Chemistry, 1978] and fumes strongly in moist air
[Stokinger, 1981].
HF is used in a variety of industrial processes involving
brick, glass, ceramics, plastics, aluminum, ferroenamels,
fluorocarbons, aerosols, welding, coal burning, rocket en-
gine fuels, high octane fuels, silicone wafer etching, dental
laboratories, ore extraction processes, phosphate fertilizers,
insecticides, and cleaning agents [Caravati, 1988; Dieffen-
bacher and Thompson, 1962; MacKinnon, 1988; Machle
and Kitzmiller, 1934; Machle et al., 1934; Mayer and Gross,
1985; Stokinger, 1981; Waldbott and Lee, 1978]. HF is
usually produced by interaction of calcium fluoride (fluor-
spar) and sulfuric acid [MacKinnon, 1988]. For HF gas,
the American Conference of Governmental Industrial Hy-
gienists ceiling limit is 3 ppm as F [ACGIH, 1994]. The
Occupational Safety and Health Administration’s Permis-
sible Exposure Limit and National Institute for Occupational
Safety and Health’s Recommended Exposure Level are both
3 ppm as well. The NIOSH Immediately Dangerous to Life
and Health Level is 30 ppm [Alexeeff et al., 1993].
Most literature related to HF injury pertains to dermal
contact. Inhalation injury due to HF has usually occurred in
industrial and laboratory settings, although at least one
forensic case has been documented [Chela et al., 1989].
Almost all documented cases resulting in significant pulmo-
nary pathology have occurred following massive exposures
[Braun et al., 1984; Caravati, 1988; Greendyke and Hodge,
1964; MacKinnon, 1988; Mayer and Guelich, 1963; Sadove
et al., 1990; Trevino et al., 1983; Watson et al., 1973; White
and Templeton, 1992]. We describe a case of chemical
pneumonitis following use of a household cleaning agent
containing HF. To our knowledge, pulmonary injury associ-
ated with use of a household product containing HF has not
been reported.
CASE REPORT
A previously healthy 26-year-old woman used mul-
tiple household products in an attempt to remove a stain
from a bathtub (see Table I for details on product contents).
She had a past medical history of ‘‘walking pneumonia’’
diagnosed without confirmatory chest radiograph a year
preceding this illness, and a 13-year history of semiannual
episodes of acute bronchitis. All these illnesses had resolved
with antibiotic therapy. She also smoked 1.5 packs of
cigarettes a day for the same 13 years. Her occupational
history was unremarkable for significant pulmonary expo-
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sures: she had not been working for 2 months preceding her
illness and had previously been an in-house care giver. She
did not use any medications. She was 178 cm tall and
weighed 115 kg.
The tub was located in a small bathroom (approxi-
mately 53 7 3 7 feet) with no ventilation other than a
heating vent. It was late fall, and the only window was
sealed shut with plastic. The door to the bathroom was kept
closed when cleaning the tub. At no time did she mix
different products, and she always rinsed the tub with cold
water before applying each different product. She wore no
gloves, using an Ajaxt pad initially and thereafter a stiff,
long-handled brush.
On day 1, she used Comett and anAjaxt pad, then 10 oz
of X-14 Mildew Stain Removert. On day 2, she tried 32 oz
of The Works Tub and Tile Cleanert; this was followed by 8
oz of ammonia. After the usual cold water rinse, she next
plugged the drain and poured in a gallon of liquid bleach,
then adding cold water. She let this sit for several minutes
before allowing to drain. On day 3, she applied 16 oz of
Sno-bolt. She next applied 16 oz of white vinegar. Later, she
applied a half-gallon of liquid bleach. As stated above, each
application was followed by a cold water rinse. She and the
other household residents did not recall any symptoms of
mucous membrane irritation up to this point in time.
At 10 PM on day 3, she applied 10 oz of Whink Rust
Removert over an estimated 30 minute interval. During this
application she experienced burning and tearing to both eyes
and a foul taste to her mouth; she did not recall experiencing
any upper or lower respiratory symptoms at that time.
However, two other household members who both used the
bathroom shortly after she applied Whink Rust Removert
recalled experiencing strong, almost unbearable eye, nose
and throat irritation.
Following the initial application, she went to a store and
obtained 2 more 10-oz bottles of Whink Rust Removert,
which she applied over an additional estimated 30-min
interval that same evening. During the second application of
Whinkt she experienced a burning sensation to the eyes and
a foul taste to her mouth (the latter persisted until breakfast
the followingmorning).Shedidnot experienceanydermal burns.
On day 4, the patient was ‘‘sleepy’’ and remained in bed
much of the day; she did not recall experiencing respiratory
symptoms through day 4. She awoke earlier than usual the
morning of day 5 with right lateral chest pain, shortness of
breath, and a nonproductive cough. She had not yet experi-
enced any fever, chills or sweats.
Before 8 AM on day 6, she was seen in the emergency
department of a local hospital. Her vitals signs were
remarkable for a respiratory rate of 28/min and a tempera-
ture of 36.2°C.Auscultation revealed rales and wheezes over
the right chest. The white blood cell (WBC) count was
14,000 with a normal differential; arterial blood (ABG) gas
values were unremarkable. A chest radiograph showed a
right lower lobe infiltrate. Refusing admission, she was
prescribed cephalexin monohydrate and ibuprofen and sent
home.
She returned to the same hospital and was admitted the
evening of day 7, complaining of severe right shoulder pain,
increased nonproductive cough, orthopnea, fevers, and chills.
Her vital signs were recorded as temperature 35.3°C, pulse
100, blood pressure 110/80, and respirations 40/min. Her
nose and throat were documented as ‘‘clear.’’ Auscultation
revealed diffuse rhonchi and wheezing over both lungs. The
leukocyte count was 13,000 with 76% segmentals, 15%
lymphocytes, 7% monocytes, and 2% eosinophils. A repeat
chest radiograph again demonstrated a right lower lobe
infiltrate. Treatment was continued with cephalexin monohy-
drate and oxygen.
On day 8, electrolytes, blood urea nitrogen (BUN), and
creatinine were normal. The leukocyte count was 14,000
with a normal differential. A chest radiograph obtained at
4:08 PM showed loss of the right heart border, with infiltrate
involving all lobes except the right upper lobe. At 5 PM she
was transferred to the coronary care unit (CCU), where she
was diuresed 2 L with Lasix and was started on erythromy-
cin, clarithromycin, cefuroxime sodium, andmethylpredniso-
l ne sodium succinate (60 mg IV q6h). Her respiratory rate
reached 45/min, and she was intubated later the same
evening.
At 1 AM of day 9, she experienced a sudden decrease in
oxygenation, requiring 100% O2, and 10 cm H2O of peak
end-expiratory pressure (PEEP) to maintain oxygen satura-
tion above 70%. Later on day 9, she was transferred to the
University of Michigan Medical Center (UMMC). She
emained on methylprednisolone sodium succinate 60 mg
q6h through the morning of day 10; then she received 1 g of
methylprednisolone sodium succinate each day for 3 more
ays. She was kept on erythromycin and began ceftriaxone
and gentamycin. She was maintained on antibiotic therapy
for the remaining 28 days of her admission at UMMC.
She experienced fevers of,38.3°C on day 9 and
several times during the next 2 weeks. Bronchoscopy with
brushings and lavage, accomplished on day 9, was consis-
tent with alveolar hemorrhage. Stains and cultures for
TABLE I. Active Ingredients of Household Cleaning Products
Product Active Ingredient
X-14 Mildew Stain RemoverT 25 to 45% sodium hypochlorite
The Works Tub and Tile CleanerT 18% phosphoric acid
Ammonia 2 to 2.5% ammonia hydroxide
Liquid bleach 5.25% sodium hypochlorite
Sno-bolT 14.5% hydrochloric acid
White vinegar 5% acetic acid
Whink Rust RemoverT 8% hydrofluoric acid
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bacteria, fungi, mycobacteria, and viruses were all negative.
Physical examination on day 10 revealed no rash, discolora-
tion, or blistering to the upper extremities. Connective tissue
disease tests were unremarkable (i.e., negative antinuclear
antibody, antinucleolar autoantibody, and anti-double-
stranded deoxyribonucleic acid assays). A chest computed
tomogram (CT) performed on day 19 showed focal bilateral
lower lobe airspace disease with extensive ground-glass
appearance of the upper lung zones—left lung greater than
right. A second bronchoscopy was accomplished day 21; the
results were significant for ‘‘yeast, notCryptococcus,’’ and
the patient was treated with IV fluconazole. A polymerase
chain reaction (PCR) test of bronchial washings for tubercu-
lin deoxyribonucleic acid was negative. Cultures for varicella,
cytomegalovirus and respiratory viruses tests were all negative.
She was extubated on day 25 but remained hospitalized
for treatment of a deep venous thrombosis and heme positive
stools through day 36. One month after discharge, she had a
persistent, nonproductive nocturnal cough and dyspnea on
climbing one flight of stairs; she had not resumed smoking.
Pulmonary function test results were consistent with mixed
mild restrictive disease and with mild to moderate obstruc-
tion in small airways (Table II).
No measurements of serum calcium were performed at
the outside hospital. Serum calciumwasmeasured at UMMCon
day 9, 6 days after exposure to theWhinkt, andwas normal.
DISCUSSION
This patient experienced hemorrhagic alveolitis and
adult respiratory disease syndrome (ARDS). The etiological
factor from her history that best explains the etiology of her
illness is her exposure to HF. There is reason to believe her
inhalational exposure to HF was adequate to initiate the
injury, and there is evidence to support a proposed mecha-
nism for such an injury.
To summarize the case history, the patient experienced
immediate irritant symptoms following use of an HF-
containing product to clean her bathtub.Within 2.5 days, she
was documented to have cough, chest pain, and a right lower
lobe infiltrate on chest radiography. After 2.5 more days,
while on oral and then intravenous antibiotic therapy, her
condition worsened with the development of ARDS, requir-
ing prolonged mechanical ventilatory support. Early bron-
choscopy (day 9) showed the presence of hemmorrhagic
alveolitis. Upon recovery she was left with a residual mixed
restrictive/obstructive pulmonary deficit.
Although it is possible that the patient’s pathology was
caused by a biological or chemical agent other than HF, HF
remains the most likely causative factor. The patient had no
recent history of exposure to illness. Testing and cultures for
a biological cause were negative, and she did not respond to
antiobiotic therapy. Although the early chest radiographs
showed a focal lesion suggestive of an infectious agent, such
focal lesions have been found to occur in animal subjects
exposed to HF [Machle and Kitzmiller, 1934; Stokinger,
1949]. The exposure in this case was of an intensity closer to
that of those animal subjects than to the massive exposures
described in most recorded human inhalation injuries.
Additionally, focal pneumonias are a known complication of
HF inhalational injury in animal subjects [Machle and
Kitzmiller, 1934]. Also, given the lower intensity of HF
exposure experienced by the patient, it is possible that her
ARDS evolved more slowly than has been recorded among
cases with massive, overwhelming exposure.
It is doubtful that the non-HF cleaning agents contrib-
uted to the patient’s pulmonary injury. The cold water rinse
between her use of ammonia hydroxide and her use of
sodium hypochlorite on day 2 would have prevented the
formation of chloramines [Reisz and Gammon, 1986]. The
patient specifically denied ever mixing any of the different
cleaning agents. Further, neither the patient nor the other
household occupants recalled experiencing irritation on
exposure to any of the non-HF containing products. And, the
chemical agents in the non-HF products would not be
expected to cause delayed-onset chemical pneumonitis as is
known to occur following exposure to HF [Braun et al., 1984].
Although HF exposure levels experienced by the patient
were not measured,Whink Rust Removert contains only 8%
HF. It has been suggested that inhalation hazard may not
exist in solutions containing less than 60% HF [Mayer and
Guelich, 1963]. Other publications suggest inhalation injury
due to HF in the absence of massive sudden exposure or
entrapment is unlikely. It is thought that the noxious effects
of gaseous HF at concentrations adequate to induce pulmo-
nary insult would drive exposed individuals away before
significant injury could occur [White and Templeton, 1992].
These opinions appear to have been derived from experience
with brief, immediately life-threatening industrial exposures
rather than more prolonged and moderate exposures. The
xposure experienced by our patient had several unique
features that suggest a mechanism whereby she could have
TABLE II. Spirometry Results Following Hospitalization for ARDS
3 weeks post-discharge 4 weeks post-discharge
Measured % Predicted Measured % Predicted
FVC 2.68 61 2.53 57
FEV1 2.12 60 2.07 58
FEV1/FVC 79 99 82 103
FEFMAX 5.22 75 5.66 81
FEF25–75 1.92 49 2.05 52
FEF25 4.57 72 5.00 78
FEF50 2.28 45 2.45 48
FEF75 0.72 25 0.79 27
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experienced an unsafe exposure to HF, which produced a
more delayed, rather than an immediate, clinical response.
The patient was working in a small, unventilated room,
and she used 3 full bottles of Whinkt in a short interval.
Further, she was physically active, scrubbing the HF-
containing product in a bathtub. The scrubbing action would
have promoted aerosolization of the HF solution; it would
also have generated some heat, increasing the volatilization
of the HF. As HF and mist are heavier than air, and as no
significant ventilation was present, these would have been at
a greater concentration within the bathtub itself. The patient
was working with her head directly over or even partially
within the bath tub, so she would have inhaled this higher
concentration of HF and HF-containing aerosol. Addition-
ally, her physical activity would have increased the rate and
depth of her respirations and would have predisposed her to
mouth breathe.
Many human nose breathers will mouth breath during
physical activity [Stavert et al., 1991]. Exercise and oronasal
and oral breathing have been associated with increased
penetration of highly water soluble chemicals to the deep
lung [Dungworth, 1989; Miller et al., 1989]. In bypassing
the nasal passageways, a significant protective mechanism
of the lungs is eliminated.
HF gas would normally (i.e., in the absence of physical
activity) be expected to deposit in the human nasal passage-
ways preferentially for several reasons. Gaseous HF is
infinitely soluble in cold water [Handbook of Chemistry and
Physics, 1978], and it has been observed that gases with
higher solubility tend to be scavenged effectively by the
upper respiratory mucosa, causing upper respiratory injury.
Intermediately soluble, and highly insoluble toxic gases tend
to have their effect on the lower respiratory mucosa [Reisz
and Gammon, 1986; White and Templeton, 1992; Morris
and Smith, 1982; Stavert et al., 1991; Dungworth, 1989;
Miller et al., 1989]. Additionally, more reactive compounds
are thought to be more effectively scavenged in the upper
airways, and HF isvery reactive at physiological pH, being a
weak acid (pK 3.45).
Once in contact with lung tissue, HF would most
probably cause cell injury via the same two mechanisms
thought to cause damage in dermal exposures: first, by
acting as a weak acid; and second, by formation of fluoride
salts with intracellular calcium and magnesium—leading to
cell death [MacKinnon, 1988].
The delay between exposure and pulmonary symptoms
in the case we describe is consistent with reported HF
inhalation injuries. With massive HF exposures, pulmonary
injury was evident in a man who died within 30 minutes of
exposure [Watson et al., 1973]. However, intraluminal
exudate can be most severe 2–3 days after exposure to a
reactive gas [Dungworth, 1989; Miller et al., 1989]. And,
death secondary to inhalation of HF has been reported to
occur days to weeks after injury [Braun et al., 1984]. We
hypothesize that with massive exposure the primary mecha-
nism of tissue injury is related to the acid properties of HF.
At lower levels of exposure, and if the patient survives the
effects of the acidic insult, salt formation by fluoride ions
may become more important in determining local pulmo-
nary tissue damage. In the present case exposure was not
overwhelming, but we believe it was adequate for the
fluoride ion to produce serious pulmonary injury.
That the patient was exposed to HF capable of causing
her pulmonary injury is further supported by the symptoms
experienced by herself and the other two adult occupants of
the house. She experienced a foul taste and eye irritation but
does not recall experiencing the nose and throat irritation
experienced by the other two adults, who visited the
bathroom near the time of theWinkt product application.All
four of these symptoms have been documented to occur at
HF concentrations as low as 12.1 ppm HF [Machle et al.,
1934]. A foul taste, described as flat and sour by Machle, has
been reported to occur at levels at least as low as 5.9 ppm
[Largent, 1961].
That the patient did not recall having experienced the
irritation described by the other two adults might be
accounted for by the known difference in symptoms experi-
enced by different subjects at specific concentrations of HF
[Largent, 1961]. However, the other two adults had expo-
sures of only a few minutes, a fraction of the time
experienced by the patient; with her more prolonged expo-
sure, she may have become acclimatized to the HF. Such an
acclimatization has been well documented in human studies
[Collings et al., 1951]. Acclimatization to HF has been
further confirmed in a study where animals exposed to 23.3
ppm HF were observed to experience mild respiratory tract
irritation which decreased after 5–15 min, when the animals
developed a mucoid discharge [Machle et al., 1934].
Whether or not acclimatization occurred, a concentra-
tion of 7.1 ppm HF has been determined to be ‘‘tolerable and
r spirable’’ in one human study involving brief exposures,
and higher concentrations were felt to be sufficiently irritat-
ing as to discourage prolonged human exposure [Machle and
Kitzmiller, 1934]. The question of whether an exposure to
7.1 ppm HF could cause pulmonary injury in an exposure
similar to that experienced by the patient in this paper is not
answered by the human studies cited in this paper. However,
animal studies suggest a potential for injury.
Stokinger [1949] foundmoderate hemorrhage and edema
in the lungs of 3 of 4 dogs exposed to 11.6 ppm HF gas for 6
hr/day over a 5-week period and that 1 of 5 dogs exposed to
3.3 ppm had a focal area of pulmonary hemorrhage.At lethal
levels, death resulted from pulmonary damage, and at
nonlethal levels, if any damage occurred it was most
frequently pulmonary damage.
Machle and Kitzmiller [1934] exposed 1 Rhesus mon-
key, 5 rabbits, and 3 guinea pigs to 7.08 ppm HF for 6 or 7
hr/day for 50 days (excluding weekends) for a total 309-hr
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exposure. The monkey suffered renal damage, but had no
pulmonary lesions. One guinea pig died after a 134-hr
exposure and was found to have a ‘‘low-grade inflammatory
reaction in the alveolar walls with atelectasis, and pro-
nounced degenerative changes and hyperplasia of the bron-
chial epithelium.’’ A second guinea pig died at 160 hr and
was found to have ‘‘a large, partly organized pulmonary
hemorrhage with low-grade cellular reaction.’’ The third
guinea pig was sacrificed 9 months after exposure and was
found to have organized pulmonary hemorrhages, alveolar
exudates, and cellular infiltrations of the alveolar walls with
irregular thickening. All four exposed rabbits had evidence
of pulmonary damage in the form of leukocytic infiltration
of the alveolar walls, with or without edema or thickening,
and their lungs were unlike those of the control rabbits.
Bronchopneumonia was the major cause of delayed death in
these animal subjects, especially among the rabbits.
While both Stokinger’s and Machle’s studies involved
much longer durations of exposure than that experienced by
the patient, concentrations that were shown to be injurious to
animals were below those described by Machle as ‘‘tolerable
and respirable’’ and at which ‘‘chronic human exposure
could easily occur’’ [Machle and Kitzmiller, 1934].
CONCLUSION
The patient described in this report suffered hemor-
rhagic alveolitis and ARDS following use of a household
cleaning product containing 8% hydrofluoric acid. The
timing, circumstances of exposure, and clinical features of
her illness would suggest HF as the cause of her illness. In
our opinion, the presence of HF in a consumer product may
be unduly hazardous.
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